Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.

作者: Hugo Lavoie , Neroshan Thevakumaran , Gwenaëlle Gavory , John J Li , Abbas Padeganeh

DOI: 10.1038/NCHEMBIO.1257

关键词:

摘要: RAF kinases have a prominent role in cancer. Their mode of activation is complex but critically requires dimerization their kinase domains. Unexpectedly, several ATP-competitive inhibitors were recently found to promote and transactivation RAS-dependent manner and, as result, undesirably stimulate RAS/ERK pathway-mediated cell growth. The mechanism by which these induce domain remains unclear. Here we describe bioluminescence resonance energy transfer-based biosensors for the extended family that enable detection living cells. Notably, demonstrate utility tools profiling selectively modulate probing structural determinants vivo. Our findings, seem generalizable other families allosterically regulated dimerization, suggest model whereby mediate stabilizing rigid closed conformation domain.

参考文章(53)
Michael Röring, Ricarda Herr, Gina J Fiala, Katharina Heilmann, Sandra Braun, Anja E Eisenhardt, Sebastian Halbach, David Capper, Andreas von Deimling, Wolfgang W Schamel, Darren N Saunders, Tilman Brummer, Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling. The EMBO Journal. ,vol. 31, pp. 2629- 2647 ,(2012) , 10.1038/EMBOJ.2012.100
Ulf R. Rapp, H. Andreas Kalmes, Christoph K. Weber, Joseph R. Slupsky, Active Ras induces heterodimerization of cRaf and BRaf. Cancer Research. ,vol. 61, pp. 3595- 3598 ,(2001)
Andreas Kalmes, Jessie Deou, Alexander W Clowes, Günter Daum, Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580 FEBS Letters. ,vol. 444, pp. 71- 74 ,(1999) , 10.1016/S0014-5793(99)00034-4
Billy Breton, Étienne Sauvageau, Joris Zhou, Hélène Bonin, Christian Le Gouill, Michel Bouvier, Multiplexing of Multicolor Bioluminescence Resonance Energy Transfer Biophysical Journal. ,vol. 99, pp. 4037- 4046 ,(2010) , 10.1016/J.BPJ.2010.10.025
David B. Solit, Neal Rosen, Resistance to BRAF inhibition in melanomas. The New England Journal of Medicine. ,vol. 364, pp. 772- 774 ,(2011) , 10.1056/NEJMCIBR1013704
Philip D. Jeffrey, Alicia A. Russo, Kornelia Polyak, Emma Gibbs, Jerard Hurwitz, Joan Massagué, Nikola P. Pavletich, Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex Nature. ,vol. 376, pp. 313- 320 ,(1995) , 10.1038/376313A0
Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul S. Lin, Richard J. Lee, Joseph Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, Keith Nolop, Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma Nature. ,vol. 467, pp. 596- 599 ,(2010) , 10.1038/NATURE09454
A Clapéron, M Therrien, KSR and CNK: two scaffolds regulating RAS-mediated RAF activation Oncogene. ,vol. 26, pp. 3143- 3158 ,(2007) , 10.1038/SJ.ONC.1210408
E. W. Joseph, C. A. Pratilas, P. I. Poulikakos, M. Tadi, W. Wang, B. S. Taylor, E. Halilovic, Y. Persaud, F. Xing, A. Viale, J. Tsai, P. B. Chapman, G. Bollag, D. B. Solit, N. Rosen, The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 14903- 14908 ,(2010) , 10.1073/PNAS.1008990107
Malha Sahmi, Martin Lefrançois, Frank Sicheri, Marc Therrien, Thanashan Rajakulendran, A dimerization-dependent mechanism drives RAF catalytic activation Nature. ,vol. 461, pp. 542- 545 ,(2009) , 10.1038/NATURE08314